Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Double-blind Study of TK-041 (Rupatadine) in Seasonal Allergic Rhinitis
jRCT2080222733Phase 3
- Sponsor
- Teikoku Seiyaku Co., Ltd.
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing Rupatadine with Placebo (2 arms).
02
Drugs
rupatadine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on jRCT2080222733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222733.